全部资讯｜CELL INTELLIGENCE

Investigating the role of costimulatory domains in enhancing CAR-T cell persistence in TNBC.

PubMed 2026/08/21 发表Cancer Gene TherQ1 · IF 6.4（JCR 2025）

The role of chimeric antigen receptor (CAR) T cell therapy in breast cancer.

PubMed 2026/08/18 发表Int ImmunopharmacolQ1 · IF 5.6（JCR 2025）

A bibliometric analysis of global research trends in adoptive cell therapy for triple negative breast cancer over the past 15 years.

PubMed 2026/06/10 发表Discov OncolQ3 · IF 2.8（JCR 2025）

过去十年间，TNBC 中 ACT 的研究显著增长，反映出未被满足的临床需求以及日益增长的科学兴趣。

Immune Checkpoint Blockade and Emerging Combination Platforms in Breast Cancer: A Narrative Review.

PubMed 2026/05/05 发表Breast Cancer (Dove Med Press)Q2 · IF 3.6（JCR 2025）

Bridging biomaterials and immunotherapy: hydrogel strategies for next-generation CAR-T cell treatment.

PubMed 2026/04/02 发表Stem Cell Res TherQ1 · IF 7.8（JCR 2025）

Modulation of Oncogenic NOTCH Signaling in Highly Aggressive Malignancies by Targeting the γ-Secretase Complex: A Systematic Review.

PubMed 2026/03/05 发表CellsQ2 · IF 6（JCR 2025）

Immunotherapy Approaches for the Treatment of Triple-Negative Breast Cancer.

PubMed 2026/01/30 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

Biogenic Selenium Nanoparticles Potentiate Anti-Mesothelin CAR-T Cell Therapy in a Syngeneic TNBC Model.

PubMed 2026/01/18 发表Transplant Cell TherQ1 · IF 4.7（JCR 2025）

AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery.

PubMed 2026/01/01 发表Iran J Basic Med SciQ2 · IF 3.2（JCR 2025）

Exploring SLAMF5/CD84 in Cancer: Advancing the Frontiers of Tumor Immunology.

PubMed 2025/08/23 发表Cell Biol IntQ3 · IF 3.5（JCR 2025）

全部资讯 32